(Q34626437)

3 August 2017

1 reference

MDMA

0 references

title

MDMA ('ecstasy') and other 'club drugs'. The new epidemic (English)

1 reference

3 August 2017

1 reference

Stephen C Koesters

1

1 reference

3 August 2017

Peter D Rogers

series ordinal

2

1 reference

3 August 2017

Christiana R Rajasingham

series ordinal

3

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Pediatric Clinics of North America

3 August 2017

published in

1 reference

3 August 2017

volume

49

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

415-433

1 reference

gamma-Hydroxybutyrate: cerebral metabolic, vascular, and protective effects.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Memory impairment in abstinent MDMA ("Ecstasy") users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Dextromethorphan and ecstasy pills

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

MDMA and human sexual function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Clinical course of gamma-hydroxybutyrate overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Naloxone antagonizes ethanol- but not gamma-hydroxybutyrate-induced sleep in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas chromatography-mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Ketamine sedation for pediatric procedures: Part 2, Review and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Ketamine in adults: what emergency physicians need to know about patient selection and emergence reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

'Ecstasy' and intracerebral haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

CORRELATION OF BLOOD LEVELS OF 4-HYDROXYBUTYRATE WITH STATE OF CONSCIOUSNESS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Reversal of the anaesthetic action of sodium gamma-hydroxybutyrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

An evaluation of gamma-hydroxybutyric acid in paediatric practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Ketamine--can chronic use impair memory?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

A review of the nonmedical use of ketamine: use, users and consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

"Designer drugs"--a current perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Causes of Alzheimer's disease: paracetamol (acetaminophen) today? Amphetamines tomorrow?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Does recreational ecstasy use cause long-term cognitive problems?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Ecstasy and neurodegeneration. Advice is that "less is more".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Effect of low doses of gamma-hydroxybutyric acid on serotonin, noradrenaline, and dopamine concentrations in rat brain areas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

7 January 2021

Ten years of 'ecstasy'

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Memory deficits associated with recreational use of "ecstasy" (MDMA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Ecstasy and new patterns of drug use: a normal population study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Recurrent hallucinations following ketamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Ethanol potentiates the toxic effects of 1,4-butanediol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Death rate from use of ecstasy or heroin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Ketamine: an update on the first twenty-five years of clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Cognitive performance amongst recreational users of "ecstasy".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Are there long-term effects of ketamine on the central nervous system?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

MDMA (ecstasy) and the rave: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Methylenedioxymethamphetamine (MDMA, "Ecstasy")

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

The background and chemistry of MDMA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

MDMA. Nonmedical use and intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Cognitive performance and serotonergic function in users of ecstasy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

7 January 2021

Gammahydroxybutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Cardiovascular reactions to gamma hydroxybutyrate in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Ketamine abusers presenting to the emergency department: a case series.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Ketamine--its pharmacology and therapeutic uses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

"Saturday night fever": ecstasy related problems in a London accident and emergency department

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

γ-Hydroxybutyrate hyperpolarizes hippocampal neurones by activating GABAB receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

Respiratory interactions of ketamine and morphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2801%2900012-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(01)00012-8

1 reference

3 August 2017

1 reference